Another placebo-controlled study 35 reported clinical improvement alongside circadian biomarker assessment, noting that seven participants had more than a 10-point decrease in DSM-III-R depression score after ALC treatment
It activates both GLP-1 and glucagon receptors, with the glucagon component being particularly relevant for hepatic fat metabolism -- a key differentiator that has driven its MASH development program
doi:10.1016/j.cgh.2006.12.004 Ceuleers H, Hanning N, Heirbaut J, et al
We ensure that candidates do not have contraindications, such as a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, to minimize potential risks associated with the medication
Kurisetty VV, Lakshmanaswamy R, Damodaran C